New tentative approval for Alembic drug dabigatran etexilate mesylate

Copyright © DrugPatentWatch. Originally published at

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs. There are three patents protecting this compound.

Drug patent litigation for DABIGATRAN ETEXILATE MESYLATE.

Nine suppliers are listed for this compound. There are ten tentative approvals for this compound.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact or visit

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top